Steakholder Foods Ltd. MTTCF

Company Overview

Steakholder Foods Ltd. is an Israel-based food technology company focused on developing cultivated meat and 3D bioprinting technologies for the alternative protein industry. Formerly known as MeaTech 3D Ltd., the company rebranded to Steakholder Foods in 2023 to reflect its broader commercial positioning within cultivated proteins and hybrid food manufacturing solutions. The company operates in the food technology and biotechnology sectors, with activities centered on cultivated beef, poultry, seafood alternatives, and advanced food-printing systems designed for industrial-scale production.

The company’s primary business lines include proprietary 3D printing platforms for alternative proteins, cultivated cell technologies, and premix formulations intended for food manufacturers. Revenue generation has historically been limited and primarily associated with research collaborations, technology development agreements, pilot projects, and commercialization initiatives rather than large-scale food sales. Steakholder Foods positions itself as a technology enabler for food producers seeking scalable manufacturing methods for cultivated and plant-based proteins. Its strategic differentiation lies in combining tissue engineering, precision deposition systems, and food-grade bio-inks into integrated production technologies aimed at improving texture, scalability, and product customization.

Business Operations

Steakholder Foods conducts operations through technology development activities focused on cultivated meat production systems and alternative protein manufacturing technologies. Its core operating areas include 3D Bioprinting Technologies, Cultivated Cell Lines, and Alternative Protein Premixes. The company develops industrial food printers capable of producing structured protein products designed to replicate the texture and appearance of conventional meat and seafood. It also develops proprietary bio-inks and formulations used within those printing systems.

The company’s operations are primarily based in Israel, though its commercialization strategy targets international food manufacturers and strategic partners across North America, Europe, and Asia-Pacific. Steakholder Foods has entered into collaborations and distribution arrangements with regional food technology and manufacturing partners to support market access and pilot deployments. The company previously operated cultivated meat subsidiaries including Peace of Meat, a Belgian cultivated-fat technology company acquired to strengthen cell-based fat development capabilities. Public filings and investor materials identify intellectual property, printing hardware, tissue engineering know-how, and cultivated cell development processes as core controlled assets.

Strategic Position & Investments

Steakholder Foods’ strategic direction centers on supplying enabling technologies to the broader alternative protein ecosystem rather than operating as a conventional consumer packaged food company. The company has emphasized scalable industrial manufacturing systems, ingredient premixes, and business-to-business partnerships intended to support food producers entering the cultivated and hybrid protein markets. Strategic initiatives have included expanding printer commercialization, developing white-label production capabilities, and advancing hybrid formulations that combine plant-based ingredients with cultivated components.

The company has invested significantly in research and development tied to cultivated meat printing, structured seafood alternatives, and digital manufacturing systems. Its acquisition of Peace of Meat expanded its cultivated-fat capabilities and strengthened its European technology footprint. Steakholder Foods has also pursued partnerships involving food manufacturers, distributors, and regional commercialization entities to accelerate adoption of its printing technologies. Public disclosures indicate continued focus on emerging sectors including cultivated seafood, precision food manufacturing, and scalable alternative protein infrastructure. Financial filings indicate the company remains in a development and commercialization stage with ongoing operating losses associated with technology development and market expansion efforts.

Geographic Footprint

Steakholder Foods is headquartered in Rehovot, Israel, where it conducts core research, engineering, and operational activities. Israel represents the company’s principal innovation and development hub, benefiting from the country’s broader cultivated meat and food technology ecosystem. The company maintains commercial ambitions across multiple international regions through partnerships, technology licensing discussions, and distribution relationships.

Its target markets include North America, Europe, Asia-Pacific, and parts of the Middle East where demand for alternative proteins and food security technologies has increased. Through prior acquisitions and collaborative arrangements, the company has established operational and strategic links beyond Israel, including technology activities associated with Belgium through Peace of Meat. Public disclosures and investor materials indicate that the company views global food manufacturers and alternative protein producers as its primary long-term customer base.

Leadership & Governance

Steakholder Foods was founded by entrepreneurs and researchers involved in biotechnology, tissue engineering, and food technology innovation. The company is publicly traded in the United States over-the-counter market under the ticker MTTCF and has also been listed on the Nasdaq Capital Market under the ticker STKH in prior reporting periods. Leadership has consistently emphasized technological scalability, industrial partnerships, and long-term participation in the alternative protein supply chain.

Key executives and leadership figures identified in public company disclosures include:

• Arik Kaufman – Chief Executive Officer
• Shahaf Bar-Geffen – Chairman of the Board
• Yaron Kaiser – Chief Financial Officer
• Ilanit Kabessa – Chief Operating Officer

The company’s governance approach, as described in public filings and investor communications, emphasizes research-driven innovation, intellectual property development, and strategic commercialization partnerships within the cultivated and alternative protein industries. Some executive appointments and organizational structures have changed over time; where discrepancies exist among older investor presentations and more recent filings, the most recent public regulatory disclosures were prioritized.